• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

悉尼帕金森病多中心研究:20年后痴呆的必然性

The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years.

作者信息

Hely Mariese A, Reid Wayne G J, Adena Michael A, Halliday Glenda M, Morris John G L

机构信息

Department of Neurology, Westmead Hospital, Westmead, New South Wales, Australia.

出版信息

Mov Disord. 2008 Apr 30;23(6):837-44. doi: 10.1002/mds.21956.

DOI:10.1002/mds.21956
PMID:18307261
Abstract

After 20 years follow-up of newly diagnosed patients with Parkinson's disease (PD), 100 of 136 (74%) have died. The mortality rate fell in the first 3 years of treatment, then rose compared to the general population, the standardized mortality ratio from 15 to 20 years reaching 3.1. Drug induced dyskinesia and end of dose failure were experienced by most patients, but the main current problems relate to the non-levodopa responsive features of the disease. Dementia is present in 83% of 20-year survivors. Dementia correlates with increasing age and probably reflects an interplay of multiple pathologies. Seventeen people with dementia had postmortems. Eight had diffuse Lewy bodies as the only cause of dementia, while others had mixed neuropathology. Only one person lives independently and 48% are in nursing homes. Excessive daytime sleepiness is noted in 70%, falls have occurred in 87%, freezing in 81%, fractures in 35%, symptomatic postural hypotension in 48%, urinary incontinence in 71%, moderate dysarthria in 81%, choking in 48%, and hallucinations in 74%. The challenge is to understand the cellular mechanisms underlying the diverse features of advanced PD that go far beyond a lack of dopamine.

摘要

对新诊断的帕金森病(PD)患者进行20年随访后,136例中有100例(74%)死亡。死亡率在治疗的前3年下降,随后与普通人群相比上升,15至20年的标准化死亡率达到3.1。大多数患者经历过药物性运动障碍和剂末失效,但目前的主要问题与该疾病对左旋多巴无反应的特征有关。20年存活者中83%存在痴呆。痴呆与年龄增长相关,可能反映了多种病理过程的相互作用。17例痴呆患者进行了尸检。8例仅有弥漫性路易体作为痴呆的唯一病因,其他患者存在混合性神经病理学改变。只有1人独立生活,48%的患者住在养老院。70%的患者存在日间过度嗜睡,87%的患者发生过跌倒,81%的患者出现冻结现象,35%的患者发生骨折,48%的患者出现症状性体位性低血压,71%的患者出现尿失禁,81%的患者存在中度构音障碍,48%的患者出现呛噎,74%的患者出现幻觉。挑战在于了解晚期帕金森病多种特征背后的细胞机制,这些特征远远超出了多巴胺缺乏的范畴。

相似文献

1
The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years.悉尼帕金森病多中心研究:20年后痴呆的必然性
Mov Disord. 2008 Apr 30;23(6):837-44. doi: 10.1002/mds.21956.
2
Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years.悉尼帕金森病多中心研究:15年后非左旋多巴反应性问题占主导地位。
Mov Disord. 2005 Feb;20(2):190-9. doi: 10.1002/mds.20324.
3
Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.在晚期帕金森病中,在已有左旋多巴治疗基础上加用多巴胺激动剂与单纯左旋多巴治疗的比较:一项荟萃分析。
Int J Clin Pract. 2009 Apr;63(4):613-23. doi: 10.1111/j.1742-1241.2009.02027.x. Epub 2009 Feb 16.
4
Parkinson's disease: progression and mortality in the L-DOPA era.帕金森病:左旋多巴时代的病情进展与死亡率
Adv Neurol. 1996;69:3-11.
5
Young-onset Parkinson's disease revisited--clinical features, natural history, and mortality.再探早发型帕金森病——临床特征、自然史及死亡率
Mov Disord. 1998 Nov;13(6):885-94. doi: 10.1002/mds.870130605.
6
Management for motor and non-motor complications in late Parkinson's disease.帕金森病晚期运动及非运动并发症的管理
Geriatrics. 2008 May;63(5):22-7.
7
Levodopa-dyskinesia incidence by age of Parkinson's disease onset.帕金森病发病年龄对应的左旋多巴诱导的异动症发生率
Mov Disord. 2005 Mar;20(3):342-4. doi: 10.1002/mds.20360.
8
[Continuous dopaminergic stimulation by Duodopa in advanced Parkinson's disease: Efficacy and safety].[多多巴持续多巴胺能刺激治疗晚期帕金森病:疗效与安全性]
Rev Neurol (Paris). 2009 Aug-Sep;165(8-9):718-27. doi: 10.1016/j.neurol.2008.11.017. Epub 2009 Jan 15.
9
Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa.对随机接受罗匹尼罗或左旋多巴初始治疗的帕金森病患者进行的十年随访。
Mov Disord. 2007 Dec;22(16):2409-17. doi: 10.1002/mds.21743.
10
[Early treatment of Parkinson's disease with levodopa].[左旋多巴对帕金森病的早期治疗]
Ned Tijdschr Geneeskd. 2009;153:A286.

引用本文的文献

1
Association of the number of minor hallucinations and well-structured visual hallucinations in Parkinson's disease.帕金森病中小幻觉数量与结构完整的视幻觉之间的关联。
NPJ Parkinsons Dis. 2025 Aug 18;11(1):244. doi: 10.1038/s41531-025-01106-9.
2
Lewy body dementia: exploring biomarkers and pathogenic interactions of amyloid β, tau, and α-synuclein.路易体痴呆:探索淀粉样β蛋白、tau蛋白和α-突触核蛋白的生物标志物及致病相互作用
Mol Neurodegener. 2025 Aug 12;20(1):90. doi: 10.1186/s13024-025-00879-0.
3
Urea cycle dysregulation drives metabolic stress and neurodegeneration in Parkinson's disease.
尿素循环失调导致帕金森病中的代谢应激和神经退行性变。
NPJ Parkinsons Dis. 2025 Aug 11;11(1):237. doi: 10.1038/s41531-025-01099-5.
4
Identifying Risk Factors and Constructing Predictive Models for Wearing-Off and Dyskinesia in Chinese Patients With Parkinson's Disease on Long-Term Levodopa Therapy.识别长期接受左旋多巴治疗的中国帕金森病患者剂末现象和异动症的风险因素并构建预测模型
CNS Neurosci Ther. 2025 Aug;31(8):e70544. doi: 10.1111/cns.70544.
5
Cortical α-synuclein pathology induces cell autonomous neuronal hypoactivity and compensatory circuit changes in a model of early Lewy body dementia.在早期路易体痴呆模型中,皮质α-突触核蛋白病变会引发细胞自主性神经元活动减退和代偿性回路变化。
bioRxiv. 2025 Aug 1:2025.07.31.668024. doi: 10.1101/2025.07.31.668024.
6
Understanding the Pre-Clinical Stages of Parkinson's Disease: Where Are We in Clinical and Research Settings?了解帕金森病的临床前期阶段:我们在临床和研究方面进展如何?
Int J Mol Sci. 2025 Jul 17;26(14):6881. doi: 10.3390/ijms26146881.
7
Subtyping Early Parkinson's Disease by Mapping Cognitive Profiles to Brain Atrophy with Visual MRI Ratings.通过视觉MRI评分将认知特征映射到脑萎缩来对早期帕金森病进行亚型分类。
Brain Sci. 2025 Jul 15;15(7):751. doi: 10.3390/brainsci15070751.
8
Gait and balance dysfunction are associated with cognitive performance only in men with Parkinson's disease.步态和平衡功能障碍仅在帕金森病男性患者中与认知表现相关。
Clin Park Relat Disord. 2025 Jul 5;13:100363. doi: 10.1016/j.prdoa.2025.100363. eCollection 2025.
9
Cognitive disorders and parkinson's disease: a literature review.认知障碍与帕金森病:文献综述
J Neural Transm (Vienna). 2025 Jul 18. doi: 10.1007/s00702-025-02983-3.
10
The application of radiomics in the diagnosis and evaluation of cognitive impairment related to neurological diseases.放射组学在神经疾病相关认知障碍诊断与评估中的应用。
Front Neurosci. 2025 Jul 2;19:1591605. doi: 10.3389/fnins.2025.1591605. eCollection 2025.